Cargando…

Paraoxonase-1 Is Not Associated with Coronary Artery Calcification in Type 2 Diabetes: Results from the PREDICT Study

Objectives: To determine any association between serum paraoxonase-1 (PON1) activity, protein and coding region genetic polymorphisms and coronary artery calcification (CACS) and to determine factors which modulate serum PON1 in type 2 diabetes (T2DM). Methods and results: 589 patients (419 Caucasia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mackness, Bharti, Marsillach, Judit, Elkeles, Robert S., Godsland, Ian F., Feher, Michael D., Rubens, Michael B., Flather, Marcus D., Humphries, Steve E., Cooper, Jackie, Mackness, Mike
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2012
Materias:	Other
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3810691/ https://www.ncbi.nlm.nih.gov/pubmed/22846213 http://dx.doi.org/10.3233/DMA-2012-0910

Ejemplares similares

Paraoxonase-1 is related to inflammation, fibrosis and PPAR delta in experimental liver disease
por: Marsillach, Judit, et al.
Publicado: (2009)

Paraoxonase-1 and -3 Protein Expression in the Brain of the Tg2576 Mouse Model of Alzheimer’s Disease
por: Salazar, Jose Gregorio, et al.
Publicado: (2021)

Paraoxonase-1 (PON1) promoter region polymorphisms, serum PON1 status and coronary heart disease
por: Mackness, Bharti, et al.
Publicado: (2013)

Decreased paraoxonase-1 activity is associated with alterations of high-density lipoprotein particles in chronic liver impairment
por: Marsillach, Judit, et al.
Publicado: (2010)

Paraoxonase-1 Inhibits Oxidized Low-Density Lipoprotein-Induced Metabolic Alterations and Apoptosis in Endothelial Cells: A Nondirected Metabolomic Study
por: García-Heredia, Anabel, et al.
Publicado: (2013)

Paraoxonase-1 (PON-1) Arylesterase Activity Levels in Patients with Coronary Artery Disease: A Meta-Analysis
por: Zuin, Marco, et al.
Publicado: (2022)

Misconceptions about paraoxonase-1
por: Mackness, Michael, et al.
Publicado: (2021)

Glycation of paraoxonase-1 inhibits its activity and impairs the ability of high-density lipoprotein to metabolize membrane lipid hydroperoxides
por: Mastorikou, M, et al.
Publicado: (2008)

Paraoxonase-1 and Other HDL Accessory Proteins in Neurological Diseases
por: Marsillach, Judit, et al.
Publicado: (2021)

Examining the role of paraoxonase 2 in the dopaminergic system of the mouse brain
por: Garrick, Jacqueline M., et al.
Publicado: (2022)

Notes on a Case of Hydrocephalus with Meningocele
por: Mackness, G. Owen C.
Publicado: (1890)

Notes on Heart Disease in Pregnancy and Labour
por: Mackness, G. Owen C.
Publicado: (1890)

Some Scarlatiniform Rashes Occurring during the Puerperium
por: Mackness, G. Owen C.
Publicado: (1888)

Some Modifications of Midwifery Forceps
por: Mackness, G. Owen C.
Publicado: (1896)

On the Relative Weights of the Placenta and Child
por: Mackness, G. Owen C.
Publicado: (1889)

The Use of Quinine as a Substitute for Ergot in Midwifery
por: Mackness, G. Owen C.
Publicado: (1898)

Notes on a Case of Placenta Prævia
por: Mackness, G. Owen C.
Publicado: (1892)

On the Relative Weights of the Placenta and Child
por: Mackness, G. Owen C.
Publicado: (1889)

Some Scarlatiniform Rashes Occurring during the Puerperium
por: Mackness, G. Owen C.
Publicado: (1888)

Notes on Heart Disease in Pregnancy and Labour
por: Mackness, G. Owen C.
Publicado: (1890)

Notes on a Case of Hydrocephalus with Meningocele
por: Mackness, G. Owen C.
Publicado: (1890)

Some Modifications of Midwifery Forceps
por: Mackness, G. Owen C.
Publicado: (1896)

Notes on a Case of Placenta Prævia
por: Mackness, G. Owen C.
Publicado: (1892)

The Use of Quinine as a Substitute for Ergot in Midwifery
por: Mackness, G. Owen C.
Publicado: (1898)

Methodological constraints in interpreting serum paraoxonase-1 activity measurements: an example from a study in HIV-infected patients
por: Parra, Sandra, et al.
Publicado: (2010)

Serum Cystatin C Is a Determinant of Paraoxonase Activity in Hemodialyzed and Renal Transplanted Patients
por: Varga, Éva, et al.
Publicado: (2009)

Report of the Royal Maternity Maternity and Simpson Memorial Hospital: For the Quarter Ending 31st October 1887
por: Maddox, R. Henry, et al.
Publicado: (1888)

Report of the Royal Maternity and Simpson Memorial Hospital for the Quarter Ending 31st October 1887
por: Maddox, R. Henry, et al.
Publicado: (1888)

Introduction to Paraoxonases
por: Aviram, Michael
Publicado: (2012)

Reduction of Paraoxonase Expression Followed by Inactivation across Independent Semiaquatic Mammals Suggests Stepwise Path to Pseudogenization
por: Graham, Allie M, et al.
Publicado: (2023)

Effects of paraoxonase activity and gene polymorphism on coronary vasomotion
por: Dunet, Vincent, et al.
Publicado: (2011)

Paraoxonase/MCS.
por: Rowat, S C
Publicado: (1999)

Biomarkers Associated with Vascular and Valvular Calcification in Chronic Hemodialysis Patients
por: Lee, Chien-Te, et al.
Publicado: (2013)

IRS1 gene variants, dysglycaemic metabolic changes and type-2 diabetes risk
por: Yiannakouris, N., et al.
Publicado: (2012)

The Structure and Function of Paraoxonase-1 and Its Comparison to Paraoxonase-2 and -3
por: Taler-Verčič, Ajda, et al.
Publicado: (2020)

Paraoxonase-1 and Simvastatin Treatment in Patients with Stable Coronary Artery Disease
por: Januszek, Rafał
Publicado: (2016)

Paraoxonase 3: Structure and Its Role in Pathophysiology of Coronary Artery Disease
por: Priyanka, Kumari, et al.
Publicado: (2019)

Human paraoxonase 2
por: Porntadavity, Sureerut, et al.
Publicado: (2010)

Paraoxonase 1 and atherosclerosis
por: Durrington, Paul N., et al.
Publicado: (2023)

Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study
por: Neil, Andrew, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_7car3iafd9rmudlnds7f5838qo